Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eiichi Araki

Showing results (11-20 of 210) with videos related to

Pageof 21
Sort By:
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|September 20, 2013
[A case of hypoglycemia caused by the accidental ingestion of glimepiride in an elderly dementia patient diagnosed based on the serum glimepiride concentration]Noriko Fujieda, Iwaho Hazekawa, Eiichi Araki
Journal of Diabetes Investigation|June 9, 2018
Impacts of tight multifactorial intervention in patients with type 2 diabetes: Implications from the Japan Diabetes Outcome Intervention Trial 3Eiichi Araki, Takafumi Senokuchi, Noboru Furukawa
Rinsho Shinkeigaku = Clinical Neurology|August 23, 2003
[A case report of spinal epidural Ki-1 lymphoma presenting acute paraplegia without spinal cord compression at the first onset]Eiichi Araki, Kimiaki Ikeda, Kiyoshi Tamura
Internal Medicine (Tokyo, Japan)|February 14, 2003
Endoplasmic reticulum stress and diabetes mellitusEiichi Araki, Seiichi Oyadomari, Masataka Mori
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 15, 2005
[Polymorphisms of PPARs and metabolic disorders]Eiichi Araki, Motoyuki Igata, Hiroyuki Motoshima, et al.
Journal of Atherosclerosis and Thrombosis|June 2, 2012
Anti-atherosclerotic potential of dihydropyridine calcium channel blockersNorio Ishii, Takeshi Matsumura, Seiya Shimoda, et al.
Journal of Diabetes Investigation|August 30, 2022
Potential of a glucagon-like peptide-1 receptor/glucose-dependent insulinotropic polypeptide receptor/glucagon receptor triagonist for the treatment of obesity and type 2 diabetesEiichi Araki, Masaji Sakaguchi, Kazuki Fukuda, et al.
Journal of Diabetes Investigation|November 14, 2022
Updates of incretin-related drugs for the treatment of type 2 diabetesHirotaka Araki, Takeshi Matsumura, Noboru Furukawa, et al.
Journal of Pharmacological Sciences|September 23, 2003
New aspects of neurotransmitter release and exocytosis: involvement of Ca2+/calmodulin-dependent phosphorylation of synapsin I in insulin exocytosisHideyuki Yamamoto, Kazuya Matsumoto, Eiichi Araki, et al.
Journal of Diabetes Investigation|October 12, 2022
Efficacy and safety of once-weekly semaglutide in Japanese individuals with type 2 diabetes in the SUSTAIN 1, 2, 5 and 9 trials: Post-hoc analysisEiichi Araki, Shinichi Harashima, Tomoyuki Nishida, et al.
Pageof 21

Showing results (11-20 of 210) with videos related to

Sort By:
Pageof 21
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|September 20, 2013
[A case of hypoglycemia caused by the accidental ingestion of glimepiride in an elderly dementia patient diagnosed based on the serum glimepiride concentration]Noriko Fujieda, Iwaho Hazekawa, Eiichi Araki
Journal of Diabetes Investigation|June 9, 2018
Impacts of tight multifactorial intervention in patients with type 2 diabetes: Implications from the Japan Diabetes Outcome Intervention Trial 3Eiichi Araki, Takafumi Senokuchi, Noboru Furukawa
Rinsho Shinkeigaku = Clinical Neurology|August 23, 2003
[A case report of spinal epidural Ki-1 lymphoma presenting acute paraplegia without spinal cord compression at the first onset]Eiichi Araki, Kimiaki Ikeda, Kiyoshi Tamura
Internal Medicine (Tokyo, Japan)|February 14, 2003
Endoplasmic reticulum stress and diabetes mellitusEiichi Araki, Seiichi Oyadomari, Masataka Mori
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 15, 2005
[Polymorphisms of PPARs and metabolic disorders]Eiichi Araki, Motoyuki Igata, Hiroyuki Motoshima, et al.
Journal of Atherosclerosis and Thrombosis|June 2, 2012
Anti-atherosclerotic potential of dihydropyridine calcium channel blockersNorio Ishii, Takeshi Matsumura, Seiya Shimoda, et al.
Journal of Diabetes Investigation|August 30, 2022
Potential of a glucagon-like peptide-1 receptor/glucose-dependent insulinotropic polypeptide receptor/glucagon receptor triagonist for the treatment of obesity and type 2 diabetesEiichi Araki, Masaji Sakaguchi, Kazuki Fukuda, et al.
Journal of Diabetes Investigation|November 14, 2022
Updates of incretin-related drugs for the treatment of type 2 diabetesHirotaka Araki, Takeshi Matsumura, Noboru Furukawa, et al.
Journal of Pharmacological Sciences|September 23, 2003
New aspects of neurotransmitter release and exocytosis: involvement of Ca2+/calmodulin-dependent phosphorylation of synapsin I in insulin exocytosisHideyuki Yamamoto, Kazuya Matsumoto, Eiichi Araki, et al.
Journal of Diabetes Investigation|October 12, 2022
Efficacy and safety of once-weekly semaglutide in Japanese individuals with type 2 diabetes in the SUSTAIN 1, 2, 5 and 9 trials: Post-hoc analysisEiichi Araki, Shinichi Harashima, Tomoyuki Nishida, et al.
Pageof 21